* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 22
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -24
cents. The lone analyst forecast for the quarter was for a loss
of 19 cents per share.
* Revenue rose 5.5% to $1.74 million from a year ago;
analysts
expected $1.74 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 22
cents.
* The company reported a quarterly loss of $7.91 million.
* InspireMD Inc shares had risen by 18.6% this quarter and
gained 5.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for InspireMD Inc is
$4.50
This summary was machine generated from LSEG data August 6 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.19 -0.22 Missed
Mar. 31 2024 -0.15 -0.21 Missed
Dec. 31 2023 -0.19 -0.16 Beat
Sep. 30 2023 -0.15 -0.15 Met